Ashok Leyland increases stake in HLFL by 3.36 per cent
Ashok Leyland increases stake in HLFL by 3.36 per cent

Ashok Leyland increases stake in HLFL by 3.36 per cent

Avalokita Pandey Article rating: 5.0

Post this acquisition, the company’s shareholding in HLFL now stands at 68.81 per cent from 65.45 per cent. The company added that this acquisition is a part of 6.99 per cent acquisition approved by the company’s board in a meeting held on March 21, 2020.

Indian Hotels Company to raise Rs 150 crore
Indian Hotels Company to raise Rs 150 crore

Indian Hotels Company to raise Rs 150 crore

Amir Shaikh Article rating: 5.0

Indian Hotels Company, on Thursday after the market hours, informed the bourses that its borrowings committee has approved the allotment of 1,500 rated, unsecured, listed, redeemable, non-convertible debentures (NCDs)

Granules India gets USFDA approval for ANDA; stock surges
Granules India gets USFDA approval for ANDA; stock surges

Granules India gets USFDA approval for ANDA; stock surges

Apurva Joshi Article rating: 4.7

Granules India has received US Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA), Trospium Chloride extended-release capsules, 60 mg.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

DSIJ Intelligence Article rating: 3.6

The market opened in the red on April 24, 2020. The previous trading session witnessed the Sensex going up by 1.54 percent to end at 31,863 and the Nifty was up 1.4 percent to close at 9,313.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

DSIJ Intelligence Article rating: 4.3

The market opened in the red on April 24, 2020. The previous trading session witnessed the Sensex going up by 1.54 percent to end at 31,863 and the Nifty was up 1.4 percent to close at 9,313.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 4.6

The market opened in the red on April 24, 2020, overall volumes in futures & options currently stand at 4,31 crore contracts with a turnover of Rs. 21,07,936.09 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 4.5

The market opened in the red on April 24, 2020, overall volumes in futures & options currently stand at 4,31 crore contracts with a turnover of Rs. 21,07,936.09 crore.

Larsen & Toubro receives order from DFCCIL
Larsen & Toubro receives order from DFCCIL

Larsen & Toubro receives order from DFCCIL

Amir Shaikh Article rating: 3.9

Railways Strategic Business Unit of L&T Construction’s Transportation Infrastructure IC in consortium with Kyosan Electric Manufacturing Co Ltd (Japan) has received a significant order in the form of three packages from Dedicated Freight Corridor Corporation of India Limited

Shilpa Medicare launches generic anticancer drug Dasatinib
Shilpa Medicare launches generic anticancer drug Dasatinib

Shilpa Medicare launches generic anticancer drug Dasatinib

Apurva Joshi Article rating: 3.5

Shilpa Medicare Limited has informed the bourses that it has launched Indian branded generic of Dasatinib, an anticancer drug with a brand name ‘Dasashil’. The drug substance patent on Dasatinib was owned by Bristol-Myers-Squibb and had expired on April 12, 2020.

RSS
First30223023302430253027302930303031Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR